Complementary and alternative medicine in diabetes care

Current Diabetes Reports

Volumn 12, Issue 6, 2012, Pages 749-761

  DiNardo, Monica M ^a,b   Gibson, Jolynn M ^c   Siminerio, Lara ^d   Morell, Allison R ^e   Lee, Edward S ^e  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b Veterans Administration Health System   (United States)

^c St Margaret Memorial Hospital   (United States)

^d Veteran's Affairs Pittsburgh Health System ^*  (United States)

^e Veteran's Affairs Pittsburgh Health System   (United States)

Author keywords

Complementary and alternative medicine; Diabetes mellitus; Herbal supplements; Insulin resistance; Mind body therapies; Nutritional supplements; Prediabetes; Type 2 diabetes

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BERBERINE; GARLIC EXTRACT; GREEN TEA EXTRACT; HEMOGLOBIN A1C; HERBACEOUS AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NATURAL PRODUCT; ORAL ANTIDIABETIC AGENT; PLACEBO; POMEGRANATE EXTRACT;

ACUPUNCTURE; ALLOPATHY; ALTERNATIVE MEDICINE; ARTICLE; AWARENESS; AYURVEDA; CARDIOVASCULAR RISK; CINNAMON; CLINICAL PRACTICE; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; ENZYME INHIBITION; ETHNICITY; EVIDENCE BASED MEDICINE; EXERCISE; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; HEALTH CARE PERSONNEL; HEMOGLOBIN BLOOD LEVEL; HERBAL MEDICINE; HUMAN; HYSTERECTOMY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIVER FUNCTION TEST; MEDITATION; MOVEMENT THERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT CARE; PORTULACA OLERACEA; QUALITY OF LIFE; REFLEXOLOGY; TAI CHI; TRANSCUTANEOUS NERVE STIMULATION; VITAMIN SUPPLEMENTATION; WELLBEING; YOGA;

EID: 84870716823     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-012-0315-2     Document Type: Article

References (70)

1. National Center for Complementary and Alternative Medicine. 5-3-2012]; Available from: http://nccam.nih.gov/.
2. Fabian E, et al. Use of complementary and alternative medicine supplements in patients with diabetes mellitus. Ann Nutr Metab. 2011;58(2):101-8.
3. Barnes PM, Bloom B, Nahin RL. Complementary and Alternative Medicine Use Among Adults and Children: United States, 2007, in National health statistics reports. Hyattsville: National Center for Health Statistics; 2008.
4. Wazaify M, et al. Complementary and alternative medicine use among Jordanian patients with diabetes. Complement Ther Clin Pract. 2011;17(2):71-5.
5. Metcalfe A, et al. Use of complementary and alternative medicine by those with a chronic disease and the general population - results of a national population based survey. BMC Complement Alternat Med. 2010;10(1):58.
6. Kim HJ, et al. Utilization patterns and cost of complementary and alternative medicine compared to conventional medicine in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;93(1):115-22.
7. Nahin RL, et al. Costs of Complementary and Alternative Medicine (CAM) and Frequency of Visits to CAMPractitioners: United States, 2007, in National health statistics reports. Hyattsville: National Center for Health Statistics; 2009.
8. SRI I. Spas and the Global Wellness Market: synergies and opportunities, in Global Spa Summit. 2010: Istanbul, Turkey. p. 33. An indepth summary of Global CAM use.
9. Ogbera AO, et al. Complementary and alternative medicine use in diabetes mellitus. West Afr J Med. 2010;29(3):158-62.
10. Hasan SS, et al. Reasons, perceived efficacy and factors associated with complementary and alternative medicine use among Malaysian patients with diabetes mellitus. Br J Diabetes Vasc Dis. 2011;11(2):92-8.
11. McCarty R, et al. Complementary and Alternative Medicine Use and Quality of Life in Pediatric Diabetes. J Altern Complement Med. 2010;16(2):165-73. One of the few cross-sectional studies of CAM use in pediatric diabetes; illustrates the emotional complexity of pediaric T1D.
12. Villa-Caballero L, et al. Ethnic differences in complementary and alternative medicine use among patients with diabetes. Complement Ther Med. 2010;18(6):241-8.
13. Dannemann K, et al. Use of complementary and alternative medicine in children with type 1 diabetes mellitus - prevalence, patterns of use, and costs. Pediatr Diabetes. 2008;9(3pt1):228-35.
14. Odegard PS, et al. Prevalence and correlates of dietary supplement use in individuals with diabetes mellitus at an acdemic diabetes care clinic. Diabetes Educ. 2011;37(3):419-25. A restrospective review showing the positive relationship in glycemic control.
15. Fenercioglu AK, et al. The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in Type 2 dabetes mellitus without compications. J Endocrinol Investig. 2010;33(2):118-24.
16. Zhang Y, et al. Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine. J Clin Endocrinol Metab. 2008;93(7):2559-65.
17. Gu Y, et al. Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta. 2010;81 (3):766-72. This study postulates that beberine may demonstrate its potent glucose-lowering effects through down-regulation of free fatty acids, potentially providing a new therepeutic target.
18. Ashraf R, Khan RA, Ashraf I. Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients. Pak J Pharm Sci. 2011;24(4):565-70.
19. Yeh GY, et al. Systematic Review of Herbs and Dietary SUPPL.ements for Glycemic Control in Diabetes. Diabetes Care. 2003;26(4):1277-94.
20. Sobenin I, et al. Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study. Acta Diabetologica. 2008;45(1):1-6.
21. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: review. J Nutr. 2002;1(4).
22. Steiner M, et al. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic and placebo administration on blood lipids. Am J Clin Nutr. 1996;64:866-70.
23. Adler AJ, Holub BJ. Effect of garlic and fresh oil supplementation on serum lipids and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr. 1997;65:455-0.
24. Abdul-Ghani MA, DeFronzo RA. Plasma glucose concentrations and prediction of future risk of type 2 diabetes. Diabetes Care. 2009;32 SUPPL. 2:S194-198.
25. Davis PA, Yokoyama W. Cinnamon intake lowers fasting blood glucose: meta-Analysis. J Med Food. 2011;14(9). Authors reviewd 6 clinical trials and concluded that cinnamon improves FBG in T2D diabetes and pre-diabetes.
26. Akilen R, et al. Glycated haemoglobin and blood pressurelowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, doubleblind clinical trial. Diabet Med. 2010;27(10):1159-67.
27. El-Sayed M-IK. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol. 2011;137(1):643-51.
28. Chen TS, et al. Efficacy of Epigallocatechin-3-Gallate and Amla (Emblica officinalis) Extract for the Treatment of Diabetic-Uremic Patien. J Med Food. 2011;14(7-8):718-23. This small study shows the effect of EGCG and Amla in enhancing antioxidant defense in uremic patients with T2D; decreases in oxidative stress resulting in overall reduction of DM complications and atherosclerotic risks.
29. Khajehdehi P, et al. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-OE≤and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled study. Scand J Urol Nephrol. 2011;45(5):365-70.
30. Campbell-Tofte JIA, et al. Randomized and double-blinded pilot clinical study of the safety and anti-diabetic efficacy of the Rauvolfia-Citrus tea, as used in Nigerian Traditional Medicine. J Ethnopharmacol. 2011;133(2):402-11.
31. Bahadoran Z, et al. Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial. CORD Conf Proc. 2011;65(8):972-7.
32. Wien M, et al. Almond Consumption and Cardiovascular Risk Factors in Adults with Prediabetes. J Am Coll Nutr. 2010;29 (3):189-97.
33. Li SC, et al. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism. 2011;60(4):474-9.
34. Marinangeli CPF, Jones PJH. Whole and fractionated yellow pea flours reduce fasting insulin and insulin resistance in hypercholesterolaemic and overweight human subjects. Hum Clin Nutr. 2011;105(1):110-7.
35. Shidfar F, et al. The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients. Int J Food Sci Nutr. 2011;62(3):289-94.
36. Taylor CG, et al. Dietary Milled Flaxseed and Flaxseed Oil Improve N-3 Fatty Acid Status and Do Not Affect Glycemic Control in Individuals with Well-Controlled Type 2 Diabetes. J Am Coll Nutr. 2010;29(1):72-80.
37. Shaw D, et al. Pharmacovigilance of herbal medicine. J Ethnopharmacol. 2012;140(3):513-8.
38. Zhang L, et al. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: Current status and future perspective. J Ethnopharmacol. 2012;140(3):519-25.
39. Hegde SV, et al. Effect of 3-Month Yoga on Oxidative Stress in Type 2 Diabetes With or Without Complications. Diabetes Care. 2011;34(10):2208-10.
40. Jyotsna VP et al. Comprehensive yogic breathing program improves quality of life in patients with diabetes. Indian J EndocrMetab. 2012. 16(423-428): p. http://www.ijem.in/text.asp?2012/16/3/423/95692.
41. Bishop SR, et al. Mindfulness: A Proposed Operational Definition. Clin Psychol Sci Pract. 2004;11(3):230-41.
42. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical consderations and preliminary results. 1982. 4: p. 33-47.
43. Ramel W, et al. The Effects of Mindfulness Meditation on Cognitive Processes and Affect in Patients with Past Depression. Cogn Ther Res. 2004;28(4):433-55.
44. Rosenzweig S, et al. Mindfulness-based stress reduction is associated with improved glycemic control in type 2 diabetes mellitus: a pilot study. Altern Ther Health Med. 2007;13(5):36-8.
45. Hartmann M, et al. Sustained Effects of a Mindfulness-Based Stress-Reduction Intervention in Type 2 Diabetic Patients. Diabetes Care. 2012;35(5):945-7.
46. Teixeira E. The effect of mindfulness meditation on painful diabetic peripheral neuropathy in adults older than 50 years. Holist Nurs Pract. 2010;24(5):277-83.
47. Moore AW, et al. Regular, brief mindfulness meditation practice improves electrophysiological markers of attentional control. Front Hum Neurosci. 2012;6.
48. Kilpatrick LA, et al. Impact of mindfulness-based stress reduction training on intrinsic brain connectivity. NeuroImage. 2011;56 (1):290-8.
49. Helms JM. An Overview of Medical Acupuncture. Altern Ther. 1998;4:35-45.
50. Kaptchuk TJ. Acunpunture: Theory, efficacy and practice. Ann Intern Med. 2002;136:374-83.
51. Ahn AC, et al. Two styles of acupuncture for treating painful diabetic neuropathy ,Äì a pilot randomised control trial. Acupunct Med. 2007;25(1-2):11-7.
52. Liang F, Koya D. Acupuncture: is it effective for treatment of insulin resistance? Diabetes Obes Metab. 2010;12:555-69. This paper reviewed the findings of 234 publications in the English language literature published between 1979 and 2009 on acupuncture for the treatment of conditions that have a component of insulin resistance. It also discussed studies of experimental evidence for the mechanism of acupuncture effects, and the methodological issues involved in acupuncture research. The authors' overall assessment was that while there is experimental evidence for plausible mechanisms for acupuncture treatment of metabolic conditions, additional, high quality clinical studies were required.
53. Kim T-H, et al. Moxibustion for managing type 2 diabetes mellitus: A systematic review. Chin J Integr Med. 2011;17(8):575-9.
54. Tong Y, Guo H, Han B. Fifteen-day Acupuncture Treatment Relieves Diabetic Peripheral Neuropathy. J Acupunct Meridian Stud. 2010;3(2):95-103.
55. Man KM, et al. Transcutaneous electrical nerve stimulation on ST36 and SP6 acupoints prevents hyperglycaemic response during anaesthesia: a randomised controlled trial. Eur J Anaesthesiol. 2011;28(6):420-6.
56. Lee MS, et al. Qigong for type 2 diabetes care: A systematic review. Complement Ther Med. 2009;17(4):236-42.
57. Liu X, et al. Qi-Gong Mind,ÄìBody Therapy and Diabetes Control: A Randomized Controlled Trial. Am J Prev Med. 2011;41(2):152-8.
58. Sun G-C, et al. Effects of Qigong on Glucose Control in Type 2 Diabetes. Diabetes Care. 2010;33(1):e8.
59. Lee MS and Ernst E. Systematic reviews of t'ai chi: an overview. Br J Sports Med. 2011.
60. Chen SC, et al. Effect of t'ai chi exercise on biochemical profiles and oxidative stress indicators in obese patients with type 2 diabetes. J Altern Complement Med. 2010;16(11):1153-9.
61. Edwards BG, Palmer J. Effects of Massage Therapy on African Americans with Type 2 Diabetes Mellitus: A Pilot Study. Complement Heal Pract Rev. 2010;15(3):149-55.
62. Wandell PE, et al. Measuring possible effect on health-related quality of life by tactile massage or relaxation in patients with type 2 diabetes. Complement Ther Med. 2012;20(1):8-15.
63. Beever R. The effects of repeated thermal therapy on quality of life in patients with type II diabetes mellitus. J Altern Complement Med. 2010;16(6):677-81.
64. Baskaran K, et al. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol. 1990;30:295-300.
65. Khare AK, Tondon RN, Tewari JP. Hypoglycaemic activity of an indigenous drug (Gymnema sylvestre, "Gurmar") in normal and diabetic persons. Indian J Physiol Pharmacol. 1983;27:257- 8.
66. Al-Romaiyan A, et al. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro. Phytother Res. 2010;24(9):1370-6. Asmall study evaluating the effects of high molecular weight Gymnemea sylvestre for the first time in vivo; demonstrated that this noved formulation of the extract directly stimulates insulin secretion in T2D.
67. Sridharan K, et al. Ayurvedic treatments for diabetes mellitus. Cochrane Database Syst Rev. 2011. doi:10.1002/14651858.CD008288.pub2. A review of whole systems CAM therapies in T2D included one study of whole systems Ayurvedic treatment and 6 trials of proprietary herbal mixtures (Diabecon, Inolter, Cogent DB, Pancreas and Hponidd) involving a total of 354 participants and controls with treatment durations ranging from 3 to 6 months. Despits postive glycemic results with 3 herbal mixtures and no reports of serious adverse events, the authors concluded that due to small sample sizes and deficient methodologies, there is insufficient evidence to recommend these practices in clinical care.
68. Singh LW. Traditional medicinal plants of Manipur as antidiabetics. J Med Plants Res. 2011;5(5):677-87.
69. Kundu PK, Chaterjee PS. Meta-Analysis of Diabecon tablets: Efficacy and safety outcomes from 15 clinical trials in diabetes mellitus. Indian J Clin Pract. 2010;20(9):653-9.
70. Saravanan G, Pari L, Venkateswaran S. Effect of cogent db, a herbal drug, on plasma insulin and hepatic enzymes of glucose metabolism in experimental diabetes. Diabetes Obes Metab. 2002;4(6):394-8.